Macular Edema - Pipeline Review, H2 2014

Global Markets Direct
August 25, 2014
59 Pages - SKU: GMD5319403
Gonorrhea - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Gonorrhea - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Gonorrhea - Pipeline Review, H2 2014’, provides an overview of the Gonorrhea’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Gonorrhea, complete with comparative  |  read more...
USD 2,000
Hand, Foot And Mouth Disease - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Hand, Foot And Mouth Disease - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Hand, Foot And Mouth Disease - Pipeline Review, H2 2014’, provides an overview of the Hand, Foot And Mouth Disease’s therapeutic pipeline. This report  |  read more...
USD 2,000
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2014’, provides an overview of the Proliferative Diabetic Retinopathy (PDR)’s therapeutic pipeline. This report provides comprehensive information  |  read more...
USD 2,000
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014’, provides an overview of the Mucopolysaccharidosis I (MPS I) (Hurler Syndrome)’s  |  read more...
USD 2,000
Mycosis Fungoides - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Mycosis Fungoides - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Mycosis Fungoides - Pipeline Review, H2 2014’, provides an overview of the Mycosis Fungoides’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Mycosis  |  read more...
USD 2,000
Germ Cell Tumors - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Germ Cell Tumors - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Germ Cell Tumors - Pipeline Review, H2 2014’, provides an overview of the Germ Cell Tumors’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014’, provides an overview of the Hormone-Sensitive Prostate Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Contact Dermatitis - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Contact Dermatitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Contact Dermatitis - Pipeline Review, H2 2014’, provides an overview of the Contact Dermatitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Contact  |  read more...
USD 2,000
Retinopathy Of Prematurity - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Retinopathy Of Prematurity - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Retinopathy Of Prematurity - Pipeline Review, H2 2014’, provides an overview of the Retinopathy Of Prematurity’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023
11/1/2014 | published by: GlobalData
EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023 Summary Type 1 diabetes is a type of diabetes that accounts for 10% of all diabetes cases. The condition occurs as a result of the autoimmune destruction  |  read more...
USD 3,995
 

SELECT A LICENSE

    Online Download  USD 2,000  
    Site License  USD 4,000  
    Global Site License  USD 6,000  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!